Recall Register

Device recall: Access Thyroglobulin assay, a simultaneous one-step immunoenzymatic assay, Catalog Number 33860

Class II FDA enforcement event 97255. Recall start date: . Status in the FDA record: Ongoing.

Reason for recall, in the words of FDA

Access Thyroglobulin reagent lot 439163 may generate erroneously high patient results. Falsely increased Access Thyroglobulin results may lead a physician to pursue unnecessary diagnostic imaging studies and/or inappropriate therapy adjustments in patients being monitored for residual or recurrent thyroid cancer.

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

Beckman Coulter, Inc. started this device recall on 10 Jul 2025. The firm address in the FDA record is in Chaska, MN. FDA put the recall in Class II. FDA event 97255 has 1 product record. The first FDA enforcement report date is 20 Aug 2025. The record gives the status Ongoing. 352 of the 945 device events that started in 2025 have more product records. The median device event of 2025 has 1 product record. The openFDA file has 945 device events that started in 2025 and 972 that started in 2024.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Worldwide - US Nationwide and the countries of Brazil, Canada, Georgia, Italy, Malaysia, Mexico, Philippines, Spain.

Recalling firm

Beckman Coulter, Inc., Chaska, MN.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 97255: product records
Recall numberProductQuantityClassStatusReport date
Z-2322-2025Access Thyroglobulin assay, a simultaneous one-step immunoenzymatic assay, Catalog Number 33860453 unitsClass IIOngoing20 Aug 2025

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Device events that started in 2025
945
Share of these events in Class II
85%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
219

Other events of the firm

Official channels

Cite this page

Recall Register. FDA enforcement event 97255. https://recallregister.com/fda/ii/97255/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA device enforcement reports
Licence
CC0 1.0
Export date
10 Nov 2026
Newest FDA report date on the register
4 Nov 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Worldwide - US Nationwide and the countries of Brazil, Canada, Georgia, Italy, Malaysia, Mexico, Philippines, Spain.
What quantity of product is in FDA event 97255?
The FDA record gives this quantity: 453 units
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many device recalls of 2025 have the same class?
85% of the 945 device events that started in 2025 are in Class II.